Geron
GERN
139 hedge funds and large institutions have $187M invested in Geron in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 39 increasing their positions, 39 reducing their positions, and 16 closing their positions.
276% more call options, than puts
Call options by funds: $3.04M | Put options by funds: $808K
0.33% more ownership
Funds ownership: 40.81% → 41.14% (+0.33%)
0% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 39
1% less capital invested
Capital invested by funds: $189M → $187M (-$2.1M)
4% less funds holding
Funds holding: 145 → 139 (-6)
25% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$7.65M |
| 2 |
Millennium Management
New York
|
+$709K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$553K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$488K |
| 5 |
Goldman Sachs
New York
|
+$266K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Charles Schwab
San Francisco,
California
|
-$1.88M |
| 2 |
VF
Virtu Financial
New York
|
-$969K |
| 3 |
State Street
Boston,
Massachusetts
|
-$907K |
| 4 |
Citigroup
New York
|
-$563K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$324K |
GERN Hedge Fund Activity: Q3 2021 in Review
139 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Geron (GERN) for Q3 2021, worth a combined $187M — down 1.1% from $189M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of GERN and 12 opened new positions — a net loss of 4 holders — while 39 trimmed existing stakes and 39 added.
The largest buyer was MPM BioImpact, opening a new position worth an estimated $7.65M. The largest seller was Charles Schwab, cutting an estimated $1.88M.
- 139 institutional investors held Geron (GERN) as of Q3 2021, down from 145 in Q2 2021.
- Funds reported $187M of Geron stock for Q3 2021, down 1.1% quarter-over-quarter.
- 12 funds opened new Geron positions in Q3 2021 and 16 closed out, a net change of -4 holders.
- The largest Geron buyer in Q3 2021 was MPM BioImpact, an estimated $7.65M added.
- The largest Geron seller in Q3 2021 was Charles Schwab, an estimated $1.88M sold.
Based on aggregated 13F filings for Q3 2021.